223 related articles for article (PubMed ID: 25872564)
1. Sudden hearing loss due to oxaliplatin use in a patient with colon cancer.
Güvenç MG; Dizdar D; Dizdar SK; Okutur SK; Demir G
J Chemother; 2016 Aug; 28(4):341-2. PubMed ID: 25872564
[TBL] [Abstract][Full Text] [Related]
2. Oxaliplatin-induced Sudden Hearing Loss in a Patient with Pancreatic Cancer.
Kim SB; Kim SY; Kim KH; Kim TN
Korean J Gastroenterol; 2020 Nov; 76(5):261-264. PubMed ID: 33234775
[TBL] [Abstract][Full Text] [Related]
3. Ototoxicity associated with oxaliplatin in a patient with pancreatic cancer.
Oh SY; Wasif N; Garcon MC; Rodriguez G; Saif MW
JOP; 2013 Nov; 14(6):676-9. PubMed ID: 24216561
[TBL] [Abstract][Full Text] [Related]
4. Acute ototoxicity from a single infusion of oxaliplatin.
Malhotra NK; Aslam R; Lipman SP; Bilski VJ
Ear Nose Throat J; 2010 Jun; 89(6):258-61. PubMed ID: 20556736
[TBL] [Abstract][Full Text] [Related]
5. Oxaliplatin-Induced Immune-Mediated Thrombocytopenia: A Case Report.
Woo HS; Lee KH; Yoon PH; Kim SJ; Park I; Kim YS; Ahn HK; Hong J; Shin DB; Sym SJ
Cancer Res Treat; 2015 Oct; 47(4):949-53. PubMed ID: 25544580
[TBL] [Abstract][Full Text] [Related]
6. Oxaliplatin-induced hemolytic anemia during adjuvant treatment of a patient with colon cancer: a case report.
Buti S; Riccò M; Chiesa MD; Copercini B; Tomasello G; Brighenti M; Passalacqua R
Anticancer Drugs; 2007 Mar; 18(3):297-300. PubMed ID: 17264762
[TBL] [Abstract][Full Text] [Related]
7. Successful desensitization to oxaliplatin.
Mis L; Fernando NH; Hurwitz HI; Morse MA
Ann Pharmacother; 2005 May; 39(5):966-9. PubMed ID: 15784807
[TBL] [Abstract][Full Text] [Related]
8. Radiation recall with oxaliplatin: report of a case and a review of the literature.
Chan RT; Au GK; Ho JW; Chu KW
Clin Oncol (R Coll Radiol); 2001; 13(1):55-7. PubMed ID: 11292139
[TBL] [Abstract][Full Text] [Related]
9. Atypical presentation of fever as hypersensitivity reaction to oxaliplatin.
Khurana A; Mitsis D; Kowlgi GN; Holle LM; Clement JM
J Oncol Pharm Pract; 2016 Apr; 22(2):319-24. PubMed ID: 25361599
[TBL] [Abstract][Full Text] [Related]
10. Oxaliplatin-induced acute tubulointerstitial nephritis: Two case reports
.
Choi YJ; Oh KH; Kang HR; Lee SJ
Clin Nephrol; 2018 Feb; 89(2):130-134. PubMed ID: 29231160
[TBL] [Abstract][Full Text] [Related]
11. Sudden-onset thrombocytopenia with oxaliplatin.
Dold FG; Mitchell EP
Ann Intern Med; 2003 Jul; 139(2):E156. PubMed ID: 12859182
[No Abstract] [Full Text] [Related]
12. Hemolytic uremic syndrome following the infusion of oxaliplatin: case report.
Dahabreh I; Tsoutsos G; Tseligas D; Janinis D
BMC Clin Pharmacol; 2006 Sep; 6():5. PubMed ID: 16968538
[TBL] [Abstract][Full Text] [Related]
13. Oxaliplatin-induced neurotoxicity: acute hyperexcitability and chronic neuropathy.
Lehky TJ; Leonard GD; Wilson RH; Grem JL; Floeter MK
Muscle Nerve; 2004 Mar; 29(3):387-92. PubMed ID: 14981738
[TBL] [Abstract][Full Text] [Related]
14. Oxaliplatin-induced ototoxicity in adjuvant setting for colorectal cancer: unusual side effect.
Hijri FZ; Arifi S; Ouattassi N; Mellas N; El Mesbahi O
J Gastrointest Cancer; 2014 Mar; 45(1):106-8. PubMed ID: 23494572
[No Abstract] [Full Text] [Related]
15. Development of nodular regenerative hyperplasia (NRH) with portal hypertension following the administration of oxaliplatin for the recurrence of colon cancer.
Takaya H; Kawaratani H; Nakanishi K; Takeyama S; Morioka C; Sawai M; Toyohara M; Fujimoto M; Yoshiji H; Yamao J; Fukui H
Intern Med; 2015; 54(4):383-7. PubMed ID: 25748953
[TBL] [Abstract][Full Text] [Related]
16. Immune-mediated thrombocytopenia resulting from sensitivity to oxaliplatin.
Curtis BR; Kaliszewski J; Marques MB; Saif MW; Nabelle L; Blank J; McFarland JG; Aster RH
Am J Hematol; 2006 Mar; 81(3):193-8. PubMed ID: 16493620
[TBL] [Abstract][Full Text] [Related]
17. Fatal oxaliplatin-induced thrombotic thrombocytopenic purpura: a case report.
Baretta Z; Falci C; Piva E; Conte P
Clin Colorectal Cancer; 2013 Dec; 12(4):294-6. PubMed ID: 24188688
[No Abstract] [Full Text] [Related]
18. Adverse reactions to oxaliplatin: a retrospective study of 25 patients treated in one institution.
Lenz G; Hacker UT; Kern W; Schalhorn A; Hiddemann W
Anticancer Drugs; 2003 Oct; 14(9):731-3. PubMed ID: 14551506
[TBL] [Abstract][Full Text] [Related]
19. Reversible bilateral blepharoptosis following oxaliplatin infusion: a case report and literature review.
Fanetti G; Ferrari LA; Pietrantonio F; Buzzoni R
Tumori; 2013; 99(5):e216-9. PubMed ID: 24501793
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of oxaliplatin in patients with severe hepatic dysfunction.
Baur M; Drescher A; Gneist M; Dittrich C; Jaehde U
Cancer Chemother Pharmacol; 2008 Jan; 61(1):97-104. PubMed ID: 17396265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
